Drug intelligence / Profile preview

Octopamine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Octopamine is an organic chemical closely related to norepinephrine and structurally similar to synephrine and tyramine. It is a member of the phenylethanolamines and tyramines. In invertebrates, octopamine functions as a major neurotransmitter involved in learning and behavior. In mammals (including humans), it acts as a trace amine found endogenously in the brain where it interacts with catecholaminergic signaling pathways. Octopamine exerts adrenergic effects primarily by acting as an agonist at beta-3 adrenergic receptor in adipocytes (fat cells), stimulating lipolysis; it has much lower affinity for mammalian alpha- or beta-adrenergic receptors compared to norepinephrine[5][7]. It has been studied experimentally as a sympathomimetic agent for hypotension but is not widely used clinically due to limited efficacy data[4][5]. Octopamine has also been promoted as a nootropic and weight loss aid; however, there is no strong evidence supporting its effectiveness for these uses[4]. All enantiomers of octopamine are prohibited by the World Anti-Doping Agency (WADA) due to their stimulant properties[1][3][4].

Brand names
EpirenorNordenNorfen
Other names
octopaminep-octopaminepara-octopaminenorsynephrine
02

Targets

ADRB3 (β3)ADRA2A (α2A)

Beyond the preview

Go deeper on Octopamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Octopamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call